{"ticker": {"uuid": "3861bff5-45ef-44d8-94f9-7a0dbef30c71", "symbol": "NEPH", "name": "Nephros Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Instruments & Supplies"}, "articles": [{"title": "Price to sales forward of Nephros, Inc. \u2013 NASDAQ:NEPH", "summary": "This page from TradingView provides a financial overview of Nephros, Inc. (NASDAQ: NEPH), specifically focusing on its forward price to sales ratio. It lists various sections related to market data, financials, news, and community discussions for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-NEPH/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-09T07:12:00", "published_display": "09 Jul 2026 07:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Announces Inclusion in the Russell Microcap Index", "summary": "Nephros, Inc. (Nasdaq: NEPH), a water technology company, has been added to the Russell Microcap Index following the 2026 annual reconstitution, effective June 26, 2026. This inclusion is expected to increase the company's visibility with institutional investors and deliver long-", "url": "https://www.marketscreener.com/news/nephros-announces-inclusion-in-the-russell-microcap-index-ce7f5ed8d88cf126", "source_name": "www.marketscreener.com", "published_at": "2026-07-07T13:12:58", "published_display": "07 Jul 2026 13:12", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Announces Inclusion in the Russell Microcap\u00ae Index", "summary": "Nephros, Inc., a water technology company, has been added to the Russell Microcap\u00ae Index, effective June 26, 2026. This inclusion is expected to increase the company's visibility among institutional investors and deliver long-term value to shareholders. The Russell indexes are wi", "url": "https://www.manilatimes.net/2026/07/06/tmt-newswire/globenewswire/nephros-announces-inclusion-in-the-russell-microcap-index/2378905", "source_name": "The Manila Times", "published_at": "2026-07-06T18:40:23", "published_display": "06 Jul 2026 18:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros added to Russell Microcap Index", "summary": "This article announces that Nephros has been added to the Russell Microcap Index. The inclusion means that Nephros will be part of the index for the upcoming year, potentially increasing its visibility and attracting new investors. This move is part of Russell's annual reconstitu", "url": "https://www.msn.com/en-us/money/markets/nephros-added-to-russell-microcap-index/ar-AA27jPrU", "source_name": "MSN", "published_at": "2026-07-06T17:09:51", "published_display": "06 Jul 2026 17:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros joins Russell Microcap Index after annual reconstitution", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPYjRITHRqU0NUeG43eDhpdDdfMndLcHMyT2hSaVNUOUtqX0szZzFtend2OWhpQzdJcnV5TVpWQ1pxdGFUZXNnZXNiSThJclFpdmVGUmFRSkRndDhzTHJTcFI3RzBRWk9EQ3R5WTdHOWNWRVp1MDZaVUNwUFJpa1FNdGhNTXhlQTJ3bnQyR1oxdnp1WGk5UjlaNzhiU3VrdHNXNkcwZVVYbFBpQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T11:00:00+00:00", "published_display": "06 Jul 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Nephros, Inc. \u2013 NASDAQ:NEPH", "summary": "This article provides the \"Price to earnings forward\" metric for Nephros, Inc. under the NASDAQ:NEPH ticker. It indicates that the market was closed with no trades at the time of the data. The content is primarily a data point presented within the TradingView platform.", "url": "https://www.tradingview.com/symbols/NASDAQ-NEPH/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T02:09:20", "published_display": "05 Jul 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Nephros, Inc. \u2013 NASDAQ:NEPH", "summary": "This article focuses on the enterprise value to EBIT forward for Nephros, Inc. (NASDAQ: NEPH). It provides navigational links to various financial data, news, and community features related to the company on the TradingView platform. The content primarily serves as a placeholder ", "url": "https://www.tradingview.com/symbols/NASDAQ-NEPH/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-02T07:09:58", "published_display": "02 Jul 2026 07:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros, Inc.(NasdaqCM: NEPH) added to Russell Microcap Index", "summary": "Nephros, Inc. (NasdaqCM: NEPH) has been added to the Russell Microcap Index, effective June 28, 2026. This inclusion is part of a broader rebalancing, also seeing Nephros added to the Russell 3000E Index and Russell Microcap Growth Benchmark. Nephros is a water technology company", "url": "https://www.marketscreener.com/news/nephros-inc-nasdaqcm-neph-added-to-russell-microcap-index-ce7f5fdcda8ff32d", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T03:40:23", "published_display": "29 Jun 2026 03:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros, Inc.(NasdaqCM: NEPH) added to Russell Microcap Growth Benchmark Index", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQd2tYLUlXb1lpd2Zrb1pKUjlYUkFLNXgxQUZXakpfZDF4clV3alJ5bW5WYXBnWGFrZUNyRHNfU3pzTmtTNzZBVXNNZ3ZyWFU0cC1OdC0xa1U4RTEwMnY5WXpFWkFFdV9nQmJhOFlGQnFCcHVjQXNUM3B0dnJ5LVVzb2lOVjZRWllPUUhlYWhHOUFQbXRTemJNdFN6U3dleGRtZlFuMkJXell3cHptejJtYnVSWlNMbW5hYTBzOFREa0M0aHF4NUE?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros | 4: Statement of changes in beneficial ownership of securities-Officer Banks Robert R. Jr.", "summary": "This document is a Statement of Changes in Beneficial Ownership of Securities (Form 4) filed by Robert R. Banks Jr., an Officer of Nephros. It reports changes in his beneficial ownership of the company's securities.", "url": "https://www.moomoo.com/news/notice/306737949/nephros-4-statement-of-changes-in-beneficial-ownership-of-securities", "source_name": "Moomoo", "published_at": "2026-06-24T15:09:54", "published_display": "24 Jun 2026 15:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Inc (NEPH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "The article discusses Nephros Inc (NEPH) and attempts to provide a breakdown of its revenue by business segments and regional contributions. However, it explicitly states that relevant data for both business and regional revenue have not been disclosed by the company. This sugges", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neph/revenue", "source_name": "TradingKey", "published_at": "2026-06-21T17:10:31", "published_display": "21 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NEPH - Nephros Inc Volatility & Greeks", "summary": "This article provides a detailed financial overview of Nephros Inc (NEPH), including its volatility, key financial metrics, stock performance, and institutional/insider ownership. It covers various valuation ratios, earnings and sales growth rates, and market indicators. The data", "url": "https://finviz.com/stock?t=NEPH&ta=1&p=d&ty=ocv&r=ytd&e=2026-03-03", "source_name": "Finviz", "published_at": "2026-06-21T17:10:31", "published_display": "21 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros to Host Virtual Investor Event: \"Beyond Filtration: The Nephros Model in Action\u201d", "summary": "Nephros, Inc. (Nasdaq: NEPH) will host a virtual investor event on July 16, 2026, titled \"Beyond Filtration: The Nephros Model in Action.\" The event aims to showcase Nephros' scalable, service-driven approach to water safety, providing insights into their responsive solutions, pa", "url": "https://www.manilatimes.net/2026/06/18/tmt-newswire/globenewswire/nephros-to-host-virtual-investor-event-beyond-filtration-the-nephros-model-in-action/2368271", "source_name": "The Manila Times", "published_at": "2026-06-19T00:12:32", "published_display": "19 Jun 2026 00:12", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in Water", "summary": "Nephros, Inc. (NEPH) is highlighting its ultrafiltration (UF) technology as a solution to the growing concern of microplastic contamination in water. The company's UF membranes are capable of removing particles as small as 0.005 microns, which includes even the smallest known mic", "url": "https://www.moomoo.com/news/post/71597528/nephros-positions-ultrafiltration-technology-as-a-solution-to-emerging-microplastic", "source_name": "Moomoo", "published_at": "2026-06-18T16:09:58", "published_display": "18 Jun 2026 16:09", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros pitches a model beyond filtration at July 16 event", "summary": "Nephros (Nasdaq: NEPH) will host a virtual investor event titled \u201cBeyond Filtration: The Nephros Model in Action\u201d on July 16, 2026, at 12:00 PM EST. The event will showcase the company's scalable, service-driven water safety model, moving beyond just filtration products, and will", "url": "https://www.stocktitan.net/news/NEPH/nephros-to-host-virtual-investor-event-beyond-filtration-the-nephros-8x6f7snpii54.html", "source_name": "Stock Titan", "published_at": "2026-06-18T11:09:05", "published_display": "18 Jun 2026 11:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros to Host Virtual Investor Event: \u201cBeyond Filtration: The Nephros Model in Action\u201d", "summary": "Nephros, Inc. will host a virtual investor event on July 16th, 2026, titled \u201cBeyond Filtration: The Nephros Model in Action.\u201d The event aims to demonstrate how Nephros is redefining water safety through a scalable, service-driven model that extends beyond filtration products, hig", "url": "https://sg.finance.yahoo.com/news/nephros-host-virtual-investor-event-110000179.html", "source_name": "Market source", "published_at": "2026-06-18T11:09:05", "published_display": "18 Jun 2026 11:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Bets on Services Over Sales: A Deeper Dive Into its 'Beyond Filtration' Play", "summary": "Nephros (Nasdaq: NEPH) is strategically shifting from a product-centric model to a service-driven ecosystem for water safety, despite its stock declining 35% in the last six months amidst record revenue and recent profits. The company's \"Beyond Filtration\" strategy leverages its ", "url": "https://briefglance.com/articles/nephros-bets-on-services-over-sales-a-deeper-dive-into-its-beyond-filtration-play", "source_name": "BriefGlance", "published_at": "2026-06-18T11:09:05", "published_display": "18 Jun 2026 11:09", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Inc (NEPH) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Nephros Inc (NEPH) focusing on its dividend and stock split history. It indicates that the company has not distributed any dividends in the past five years and has no recorded stock splits. The page also displays current stock price details an", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neph/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T05:40:28", "published_display": "18 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Inc (NEPH) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Nephros Inc (NEPH), listing major shareholders and their respective proportion of holdings. It also provides institutional shareholding data over several quarters and recent shareholder activity, noting changes in individual and i", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neph/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T05:40:28", "published_display": "18 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Inc (NEPH) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for Nephros Inc (NEPH), highlighting its current earnings forecast score of 8.00 and an average price target of $7.00 based on ratings from two analysts. It indicates an expected revenue of $5.05 million for the next quarter and suggests", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neph/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T22:39:05", "published_display": "17 Jun 2026 22:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Inc (NEPH) Financial Health: Profitability & Balance Sheet Analysis", "summary": "Nephros Inc (NEPH) has a current financial score of 6.40, placing it 121 out of 161 in the Professional & Commercial Services industry. The company's financial status is described as robust, with low operating efficiency. Its latest quarterly revenue increased by 6.87% year-over-", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neph/financial-health", "source_name": "TradingKey", "published_at": "2026-06-17T10:10:34", "published_display": "17 Jun 2026 10:10", "sentiment": "positive", "sentiment_pct": 76, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is Nephros Drawing Attention In The Water Filtration Industry?", "summary": "Nephros (NEPH) is gaining attention in the water filtration industry due to increasing focus on healthcare water safety, infrastructure improvements, and advancements in filtration technology. The company specializes in developing and supplying water filtration technologies for h", "url": "https://kalkinemedia.com/us/stocks/healthcare/why-is-nephros-drawing-attention-in-the-water-filtration-industry", "source_name": "Kalkine Media", "published_at": "2026-06-17T04:11:15", "published_display": "17 Jun 2026 04:11", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Inc (NEPH) Institutional Confidence", "summary": "Nephros Inc (NEPH) has an institutional shareholding score of 5.00, placing it 98th out of 161 in the Professional & Commercial Services industry. The institutional shareholding proportion is 50.96%, reflecting a 6.10% increase quarter-over-quarter. James Simons is the largest in", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neph/sentiment", "source_name": "TradingKey", "published_at": "2026-06-17T03:11:15", "published_display": "17 Jun 2026 03:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Inc (NEPH) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Nephros Inc (NEPH), detailing its current price momentum score, support and resistance levels, and insights from various technical indicators. It shows that NEPH currently has a price momentum score of 6.67 and is trading between a re", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neph/technical", "source_name": "TradingKey", "published_at": "2026-06-17T03:11:15", "published_display": "17 Jun 2026 03:11", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros highlights filtration technology for microplastics removal", "summary": "Nephros Inc. announced that its ultrafiltration technology effectively removes microplastics and nanoplastics from drinking water, a capability highlighted after the U.S. EPA included microplastics as a priority contaminant. Despite a 23% revenue growth to $19.1 million and stron", "url": "https://www.investing.com/news/company-news/nephros-highlights-filtration-technology-for-microplastics-removal-93CH-4744465", "source_name": "Investing.com", "published_at": "2026-06-16T11:09:46", "published_display": "16 Jun 2026 11:09", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros posts updated 2026 corporate presentation on website", "summary": "Nephros (NEPH) has posted an updated 2026 corporate presentation on its website, disclosed via an 8-K filing Item 7.01. This update, furnished as Exhibit 99.1 to the SEC filing, provides public information in accordance with Regulation FD. The presentation is available on the com", "url": "https://www.tradingview.com/news/tradingview:b0d62d0a856ca:0-nephros-posts-updated-2026-corporate-presentation-on-website/", "source_name": "TradingView", "published_at": "2026-06-15T09:39:53", "published_display": "15 Jun 2026 09:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros (NASDAQ: NEPH) posts updated 2026 corporate presentation online", "summary": "Nephros, Inc. (NASDAQ: NEPH) announced that it posted an updated 2026 Corporate Presentation on its website on June 12, 2026, and furnished it as Exhibit 99.1 to a current report on Form 8-K. The company specified that this presentation is provided as public information and is \"f", "url": "https://www.stocktitan.net/sec-filings/NEPH/8-k-nephros-inc-reports-material-event-c0251a8408e5.html", "source_name": "Stock Titan", "published_at": "2026-06-13T20:39:53", "published_display": "13 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros (NEPH) director awarded 3,574 shares and holds options expiring 2034\u20132035", "summary": "Nephros Inc. director Arthur H. Amron received an equity grant of 3,574 shares of Common Stock as compensation for board service, increasing his direct holdings to 138,456 shares. He also holds outstanding stock options for 7,050 shares exercisable at $1.47 expiring in 2035 and 7", "url": "https://www.stocktitan.net/sec-filings/NEPH/form-4-nephros-inc-insider-trading-activity-e9585976acf7.html", "source_name": "Stock Titan", "published_at": "2026-06-12T21:39:25", "published_display": "12 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Q1 2026 Earnings: EPS Slightly Misses Estimate, Stock Dips 4.7% - Guidance Accuracy Score", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOWkZWdTRzOGx5Rmd0MDNhZ3RNSXpwMUk3ODRQLVhBM1NyNmdWY2kwcDBqV0dIMDRYRGQxb1ZBUldYa2xnZlRFOGM3Z0lmeG5RY2h4SmZDbXU3SEdUYW5hVWJyQUJZZ2JTOXA2NDhLeGl5N2YzR1BqelhORzJtelNLUG1Ec1Vrem1aRUVESDRRUXdycTFSbk94TkF3MnZlQXVMNkViUk5iTzYzbGZNUUhTMlJPNVhsQQ?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-06T07:00:00+00:00", "published_display": "06 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NEPH - Nephros Inc Stock Price and Quote", "summary": "This page provides a comprehensive overview of Nephros Inc. (NEPH) stock, including its current price, key financial metrics, performance indicators, and recent news and events. It lists insider transactions, analyst ratings, and historical financial activities, alongside company", "url": "https://finviz.com/stock?t=NEPH", "source_name": "Finviz", "published_at": "2026-06-02T16:09:58", "published_display": "02 Jun 2026 16:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Inc. (NEPH) Edges Higher Amid Positive Momentum - Wyckoff Spring", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNcEJKN0dQeDVkRDJfczhfdEJQUU1EeWJiTzlCckZ2dHcta0UyTHBhNmVRSnNmYlU2WWZpSGVJLUdLTzlXem8zOFI3ak5ic3RzUDFYN0l5U2dYdWFhYWt1ZDRTUkQ1ODhNZ0w4ZDE4Q1RiaWxrQWFtdUQtTkR2eU5OTS1ra1BxY0V0RVZRRTMtMHd3U3Vxbkp3N2NEOFYxdDhzUWg5Yw?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros, Inc. (NASDAQ:NEPH) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.00", "summary": "Nephros, Inc. (NASDAQ:NEPH) shareholders experienced a 15% surge in shares after the company released its latest quarterly results. The company slightly exceeded revenue expectations at US$5.2m, and its statutory EPS aligned with analyst appraisals at US$0.01. Following these res", "url": "https://www.moomoo.com/news/post/69752840/nephros-inc-nasdaq-neph-released-earnings-last-week-and-analysts", "source_name": "Moomoo", "published_at": "2026-05-11T18:39:01", "published_display": "11 May 2026 18:39", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US$7.00 - That's What Analysts Think Nephros, Inc. (NASDAQ:NEPH) Is Worth After These Results", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/us-7-00-thats-analysts-115014770.html", "source_name": "Simply Wall St.", "published_at": "2026-05-11T11:50:14+00:00", "published_display": "11 May 2026 11:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros, Inc. (NASDAQ:NEPH) Just Reported And Analysts Have Been Lifting Their Price Targets", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros (NEPH) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/c7bf4a95-319f-314d-8718-c46c3d2138dc/nephros-%28neph%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-08T20:10:16+00:00", "published_display": "08 May 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/3dce6705-1f0a-305d-85e1-2a860507bb13/nephros%2C-inc.-q1-2026.html", "source_name": "Moby", "published_at": "2026-05-08T12:30:00+00:00", "published_display": "08 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Announces Financial Results for Quarter Ended March 31, 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/nephros-announces-financial-results-quarter-200500912.html", "source_name": "GlobeNewswire", "published_at": "2026-05-07T20:05:00+00:00", "published_display": "07 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Schedules First Quarter 2026 Financial Results Conference Call", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/nephros-schedules-first-quarter-2026-200000624.html", "source_name": "GlobeNewswire", "published_at": "2026-04-30T20:00:00+00:00", "published_display": "30 Apr 2026 20:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros, Inc. Expands Regional Focus in Greater New York City with Appointment of Dana Cunningham as Sales Leader", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPVTM1aGtjTHdnQVd5ZzJLZGlhQlRvVTZzelBEMDVLdEp3V09HTDBzc3VYNmFoYXJ2MjhYRnp1TWRlaVMtRkdYX2o3ekZfWHF4a292R2xmUDN5NmlmLUVOZFRDeHQ3b280a3FrRW5LREJyck8wTExDaXpKMll4Q1RmSkg0eDFDakRKWHhqX3ZqQTlNTTQ0VHNDYlJxbjRqZ3pQdTlFMWNXN09uTS10SHNRY2IyYmxneTNtc2pVY3BRRUR0QUJSUmx0eXZabFcxajJPY0hTTS1pYVJCV1NqYXF0T3BB?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros, Inc.'s (NASDAQ:NEPH) Popularity With Investors Under Threat As Stock Sinks 28%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros (NEPH) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBqVlR2WTVlb29pVWRnTm0ycG9SazFnblY4VlNhU195NnhMZ1BkX3VSbXNtdjMxd1NOLTE4dFZyc3ZFRVVVWG5uZlp6QUNXb1phbm9n?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T00:05:10+00:00", "published_display": "25 Apr 2025 00:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What is the current Price Target and Forecast for Nephros (NEPH)", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTFByd29NcDdZRkhTR0hxa3lFYkRKNmhyRXNoelZxc19aS29RN2xjN1Q0UWwyUUVJcUxnMFIwQ3Z1WWpTSXRWelh4YURmOGdNUDJ4MTdjTFlYNmFyU21yM3FSRTg4QVVXOFVLWHlZeUVrc09nSmtYNHJnNQ?oc=5", "source_name": "Zacks Investment Research", "published_at": "2023-05-03T07:07:22+00:00", "published_display": "03 May 2023 07:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Stock Price Forecast. Should You Buy NEPH?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSEFVX3lxTFAySThsWGMxdWdrRkRXMjdDWkhjVVRuSTkxdmRnNHZjTVlxQ25oNFFFcjZqTlFrSnloRlk3OUx2dlFBRmg3Q29VVg?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-01T20:28:58+00:00", "published_display": "01 Dec 2020 20:28", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should I buy Nephros (NEPH)", "summary": "", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE55Q0xwMUlaM09PRE93N0xRWFRSVkt1bEZCb1l0WUxmQ3hOMUdEaVBqY3h3S3RTVzB0ME1fN2VON01JTUxYejZ0enIxTTRPU2V6VVJVZERBbDNpR0tORnFEZ2tzaUJLRUxrN3R4Uw?oc=5", "source_name": "Zacks Investment Research", "published_at": "2016-08-05T20:33:11+00:00", "published_display": "05 Aug 2016 20:33", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Price to sales forward of Nephros, Inc. \u2013 NASDAQ:NEPH", "summary": "This page from TradingView provides a financial overview of Nephros, Inc. (NASDAQ: NEPH), specifically focusing on its forward price to sales ratio. It lists various sections related to market data, financials, news, and community discussions for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-NEPH/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-09T07:12:00", "published_display": "09 Jul 2026 07:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Announces Inclusion in the Russell Microcap Index", "summary": "Nephros, Inc. (Nasdaq: NEPH), a water technology company, has been added to the Russell Microcap Index following the 2026 annual reconstitution, effective June 26, 2026. This inclusion is expected to increase the company's visibility with institutional investors and deliver long-", "url": "https://www.marketscreener.com/news/nephros-announces-inclusion-in-the-russell-microcap-index-ce7f5ed8d88cf126", "source_name": "www.marketscreener.com", "published_at": "2026-07-07T13:12:58", "published_display": "07 Jul 2026 13:12", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Announces Inclusion in the Russell Microcap\u00ae Index", "summary": "Nephros, Inc., a water technology company, has been added to the Russell Microcap\u00ae Index, effective June 26, 2026. This inclusion is expected to increase the company's visibility among institutional investors and deliver long-term value to shareholders. The Russell indexes are wi", "url": "https://www.manilatimes.net/2026/07/06/tmt-newswire/globenewswire/nephros-announces-inclusion-in-the-russell-microcap-index/2378905", "source_name": "The Manila Times", "published_at": "2026-07-06T18:40:23", "published_display": "06 Jul 2026 18:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros added to Russell Microcap Index", "summary": "This article announces that Nephros has been added to the Russell Microcap Index. The inclusion means that Nephros will be part of the index for the upcoming year, potentially increasing its visibility and attracting new investors. This move is part of Russell's annual reconstitu", "url": "https://www.msn.com/en-us/money/markets/nephros-added-to-russell-microcap-index/ar-AA27jPrU", "source_name": "MSN", "published_at": "2026-07-06T17:09:51", "published_display": "06 Jul 2026 17:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros joins Russell Microcap Index after annual reconstitution", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPYjRITHRqU0NUeG43eDhpdDdfMndLcHMyT2hSaVNUOUtqX0szZzFtend2OWhpQzdJcnV5TVpWQ1pxdGFUZXNnZXNiSThJclFpdmVGUmFRSkRndDhzTHJTcFI3RzBRWk9EQ3R5WTdHOWNWRVp1MDZaVUNwUFJpa1FNdGhNTXhlQTJ3bnQyR1oxdnp1WGk5UjlaNzhiU3VrdHNXNkcwZVVYbFBpQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T11:00:00+00:00", "published_display": "06 Jul 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Nephros, Inc. \u2013 NASDAQ:NEPH", "summary": "This article provides the \"Price to earnings forward\" metric for Nephros, Inc. under the NASDAQ:NEPH ticker. It indicates that the market was closed with no trades at the time of the data. The content is primarily a data point presented within the TradingView platform.", "url": "https://www.tradingview.com/symbols/NASDAQ-NEPH/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T02:09:20", "published_display": "05 Jul 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Nephros, Inc. \u2013 NASDAQ:NEPH", "summary": "This article focuses on the enterprise value to EBIT forward for Nephros, Inc. (NASDAQ: NEPH). It provides navigational links to various financial data, news, and community features related to the company on the TradingView platform. The content primarily serves as a placeholder ", "url": "https://www.tradingview.com/symbols/NASDAQ-NEPH/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-02T07:09:58", "published_display": "02 Jul 2026 07:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros, Inc.(NasdaqCM: NEPH) added to Russell Microcap Index", "summary": "Nephros, Inc. (NasdaqCM: NEPH) has been added to the Russell Microcap Index, effective June 28, 2026. This inclusion is part of a broader rebalancing, also seeing Nephros added to the Russell 3000E Index and Russell Microcap Growth Benchmark. Nephros is a water technology company", "url": "https://www.marketscreener.com/news/nephros-inc-nasdaqcm-neph-added-to-russell-microcap-index-ce7f5fdcda8ff32d", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T03:40:23", "published_display": "29 Jun 2026 03:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros, Inc.(NasdaqCM: NEPH) added to Russell Microcap Growth Benchmark Index", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQd2tYLUlXb1lpd2Zrb1pKUjlYUkFLNXgxQUZXakpfZDF4clV3alJ5bW5WYXBnWGFrZUNyRHNfU3pzTmtTNzZBVXNNZ3ZyWFU0cC1OdC0xa1U4RTEwMnY5WXpFWkFFdV9nQmJhOFlGQnFCcHVjQXNUM3B0dnJ5LVVzb2lOVjZRWllPUUhlYWhHOUFQbXRTemJNdFN6U3dleGRtZlFuMkJXell3cHptejJtYnVSWlNMbW5hYTBzOFREa0M0aHF4NUE?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros | 4: Statement of changes in beneficial ownership of securities-Officer Banks Robert R. Jr.", "summary": "This document is a Statement of Changes in Beneficial Ownership of Securities (Form 4) filed by Robert R. Banks Jr., an Officer of Nephros. It reports changes in his beneficial ownership of the company's securities.", "url": "https://www.moomoo.com/news/notice/306737949/nephros-4-statement-of-changes-in-beneficial-ownership-of-securities", "source_name": "Moomoo", "published_at": "2026-06-24T15:09:54", "published_display": "24 Jun 2026 15:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Inc (NEPH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "The article discusses Nephros Inc (NEPH) and attempts to provide a breakdown of its revenue by business segments and regional contributions. However, it explicitly states that relevant data for both business and regional revenue have not been disclosed by the company. This sugges", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neph/revenue", "source_name": "TradingKey", "published_at": "2026-06-21T17:10:31", "published_display": "21 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NEPH - Nephros Inc Volatility & Greeks", "summary": "This article provides a detailed financial overview of Nephros Inc (NEPH), including its volatility, key financial metrics, stock performance, and institutional/insider ownership. It covers various valuation ratios, earnings and sales growth rates, and market indicators. The data", "url": "https://finviz.com/stock?t=NEPH&ta=1&p=d&ty=ocv&r=ytd&e=2026-03-03", "source_name": "Finviz", "published_at": "2026-06-21T17:10:31", "published_display": "21 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros to Host Virtual Investor Event: \"Beyond Filtration: The Nephros Model in Action\u201d", "summary": "Nephros, Inc. (Nasdaq: NEPH) will host a virtual investor event on July 16, 2026, titled \"Beyond Filtration: The Nephros Model in Action.\" The event aims to showcase Nephros' scalable, service-driven approach to water safety, providing insights into their responsive solutions, pa", "url": "https://www.manilatimes.net/2026/06/18/tmt-newswire/globenewswire/nephros-to-host-virtual-investor-event-beyond-filtration-the-nephros-model-in-action/2368271", "source_name": "The Manila Times", "published_at": "2026-06-19T00:12:32", "published_display": "19 Jun 2026 00:12", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in Water", "summary": "Nephros, Inc. (NEPH) is highlighting its ultrafiltration (UF) technology as a solution to the growing concern of microplastic contamination in water. The company's UF membranes are capable of removing particles as small as 0.005 microns, which includes even the smallest known mic", "url": "https://www.moomoo.com/news/post/71597528/nephros-positions-ultrafiltration-technology-as-a-solution-to-emerging-microplastic", "source_name": "Moomoo", "published_at": "2026-06-18T16:09:58", "published_display": "18 Jun 2026 16:09", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros pitches a model beyond filtration at July 16 event", "summary": "Nephros (Nasdaq: NEPH) will host a virtual investor event titled \u201cBeyond Filtration: The Nephros Model in Action\u201d on July 16, 2026, at 12:00 PM EST. The event will showcase the company's scalable, service-driven water safety model, moving beyond just filtration products, and will", "url": "https://www.stocktitan.net/news/NEPH/nephros-to-host-virtual-investor-event-beyond-filtration-the-nephros-8x6f7snpii54.html", "source_name": "Stock Titan", "published_at": "2026-06-18T11:09:05", "published_display": "18 Jun 2026 11:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros to Host Virtual Investor Event: \u201cBeyond Filtration: The Nephros Model in Action\u201d", "summary": "Nephros, Inc. will host a virtual investor event on July 16th, 2026, titled \u201cBeyond Filtration: The Nephros Model in Action.\u201d The event aims to demonstrate how Nephros is redefining water safety through a scalable, service-driven model that extends beyond filtration products, hig", "url": "https://sg.finance.yahoo.com/news/nephros-host-virtual-investor-event-110000179.html", "source_name": "Market source", "published_at": "2026-06-18T11:09:05", "published_display": "18 Jun 2026 11:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Bets on Services Over Sales: A Deeper Dive Into its 'Beyond Filtration' Play", "summary": "Nephros (Nasdaq: NEPH) is strategically shifting from a product-centric model to a service-driven ecosystem for water safety, despite its stock declining 35% in the last six months amidst record revenue and recent profits. The company's \"Beyond Filtration\" strategy leverages its ", "url": "https://briefglance.com/articles/nephros-bets-on-services-over-sales-a-deeper-dive-into-its-beyond-filtration-play", "source_name": "BriefGlance", "published_at": "2026-06-18T11:09:05", "published_display": "18 Jun 2026 11:09", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Inc (NEPH) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Nephros Inc (NEPH) focusing on its dividend and stock split history. It indicates that the company has not distributed any dividends in the past five years and has no recorded stock splits. The page also displays current stock price details an", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neph/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T05:40:28", "published_display": "18 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Inc (NEPH) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Nephros Inc (NEPH), listing major shareholders and their respective proportion of holdings. It also provides institutional shareholding data over several quarters and recent shareholder activity, noting changes in individual and i", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neph/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T05:40:28", "published_display": "18 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Inc (NEPH) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for Nephros Inc (NEPH), highlighting its current earnings forecast score of 8.00 and an average price target of $7.00 based on ratings from two analysts. It indicates an expected revenue of $5.05 million for the next quarter and suggests", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neph/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T22:39:05", "published_display": "17 Jun 2026 22:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Inc (NEPH) Financial Health: Profitability & Balance Sheet Analysis", "summary": "Nephros Inc (NEPH) has a current financial score of 6.40, placing it 121 out of 161 in the Professional & Commercial Services industry. The company's financial status is described as robust, with low operating efficiency. Its latest quarterly revenue increased by 6.87% year-over-", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neph/financial-health", "source_name": "TradingKey", "published_at": "2026-06-17T10:10:34", "published_display": "17 Jun 2026 10:10", "sentiment": "positive", "sentiment_pct": 76, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is Nephros Drawing Attention In The Water Filtration Industry?", "summary": "Nephros (NEPH) is gaining attention in the water filtration industry due to increasing focus on healthcare water safety, infrastructure improvements, and advancements in filtration technology. The company specializes in developing and supplying water filtration technologies for h", "url": "https://kalkinemedia.com/us/stocks/healthcare/why-is-nephros-drawing-attention-in-the-water-filtration-industry", "source_name": "Kalkine Media", "published_at": "2026-06-17T04:11:15", "published_display": "17 Jun 2026 04:11", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Inc (NEPH) Institutional Confidence", "summary": "Nephros Inc (NEPH) has an institutional shareholding score of 5.00, placing it 98th out of 161 in the Professional & Commercial Services industry. The institutional shareholding proportion is 50.96%, reflecting a 6.10% increase quarter-over-quarter. James Simons is the largest in", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neph/sentiment", "source_name": "TradingKey", "published_at": "2026-06-17T03:11:15", "published_display": "17 Jun 2026 03:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Inc (NEPH) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Nephros Inc (NEPH), detailing its current price momentum score, support and resistance levels, and insights from various technical indicators. It shows that NEPH currently has a price momentum score of 6.67 and is trading between a re", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-neph/technical", "source_name": "TradingKey", "published_at": "2026-06-17T03:11:15", "published_display": "17 Jun 2026 03:11", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros highlights filtration technology for microplastics removal", "summary": "Nephros Inc. announced that its ultrafiltration technology effectively removes microplastics and nanoplastics from drinking water, a capability highlighted after the U.S. EPA included microplastics as a priority contaminant. Despite a 23% revenue growth to $19.1 million and stron", "url": "https://www.investing.com/news/company-news/nephros-highlights-filtration-technology-for-microplastics-removal-93CH-4744465", "source_name": "Investing.com", "published_at": "2026-06-16T11:09:46", "published_display": "16 Jun 2026 11:09", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros posts updated 2026 corporate presentation on website", "summary": "Nephros (NEPH) has posted an updated 2026 corporate presentation on its website, disclosed via an 8-K filing Item 7.01. This update, furnished as Exhibit 99.1 to the SEC filing, provides public information in accordance with Regulation FD. The presentation is available on the com", "url": "https://www.tradingview.com/news/tradingview:b0d62d0a856ca:0-nephros-posts-updated-2026-corporate-presentation-on-website/", "source_name": "TradingView", "published_at": "2026-06-15T09:39:53", "published_display": "15 Jun 2026 09:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros (NASDAQ: NEPH) posts updated 2026 corporate presentation online", "summary": "Nephros, Inc. (NASDAQ: NEPH) announced that it posted an updated 2026 Corporate Presentation on its website on June 12, 2026, and furnished it as Exhibit 99.1 to a current report on Form 8-K. The company specified that this presentation is provided as public information and is \"f", "url": "https://www.stocktitan.net/sec-filings/NEPH/8-k-nephros-inc-reports-material-event-c0251a8408e5.html", "source_name": "Stock Titan", "published_at": "2026-06-13T20:39:53", "published_display": "13 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros (NEPH) director awarded 3,574 shares and holds options expiring 2034\u20132035", "summary": "Nephros Inc. director Arthur H. Amron received an equity grant of 3,574 shares of Common Stock as compensation for board service, increasing his direct holdings to 138,456 shares. He also holds outstanding stock options for 7,050 shares exercisable at $1.47 expiring in 2035 and 7", "url": "https://www.stocktitan.net/sec-filings/NEPH/form-4-nephros-inc-insider-trading-activity-e9585976acf7.html", "source_name": "Stock Titan", "published_at": "2026-06-12T21:39:25", "published_display": "12 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Q1 2026 Earnings: EPS Slightly Misses Estimate, Stock Dips 4.7% - Guidance Accuracy Score", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOWkZWdTRzOGx5Rmd0MDNhZ3RNSXpwMUk3ODRQLVhBM1NyNmdWY2kwcDBqV0dIMDRYRGQxb1ZBUldYa2xnZlRFOGM3Z0lmeG5RY2h4SmZDbXU3SEdUYW5hVWJyQUJZZ2JTOXA2NDhLeGl5N2YzR1BqelhORzJtelNLUG1Ec1Vrem1aRUVESDRRUXdycTFSbk94TkF3MnZlQXVMNkViUk5iTzYzbGZNUUhTMlJPNVhsQQ?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-06T07:00:00+00:00", "published_display": "06 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NEPH - Nephros Inc Stock Price and Quote", "summary": "This page provides a comprehensive overview of Nephros Inc. (NEPH) stock, including its current price, key financial metrics, performance indicators, and recent news and events. It lists insider transactions, analyst ratings, and historical financial activities, alongside company", "url": "https://finviz.com/stock?t=NEPH", "source_name": "Finviz", "published_at": "2026-06-02T16:09:58", "published_display": "02 Jun 2026 16:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Inc. (NEPH) Edges Higher Amid Positive Momentum - Wyckoff Spring", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNcEJKN0dQeDVkRDJfczhfdEJQUU1EeWJiTzlCckZ2dHcta0UyTHBhNmVRSnNmYlU2WWZpSGVJLUdLTzlXem8zOFI3ak5ic3RzUDFYN0l5U2dYdWFhYWt1ZDRTUkQ1ODhNZ0w4ZDE4Q1RiaWxrQWFtdUQtTkR2eU5OTS1ra1BxY0V0RVZRRTMtMHd3U3Vxbkp3N2NEOFYxdDhzUWg5Yw?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros, Inc. (NASDAQ:NEPH) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.00", "summary": "Nephros, Inc. (NASDAQ:NEPH) shareholders experienced a 15% surge in shares after the company released its latest quarterly results. The company slightly exceeded revenue expectations at US$5.2m, and its statutory EPS aligned with analyst appraisals at US$0.01. Following these res", "url": "https://www.moomoo.com/news/post/69752840/nephros-inc-nasdaq-neph-released-earnings-last-week-and-analysts", "source_name": "Moomoo", "published_at": "2026-05-11T18:39:01", "published_display": "11 May 2026 18:39", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US$7.00 - That's What Analysts Think Nephros, Inc. (NASDAQ:NEPH) Is Worth After These Results", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/us-7-00-thats-analysts-115014770.html", "source_name": "Simply Wall St.", "published_at": "2026-05-11T11:50:14+00:00", "published_display": "11 May 2026 11:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros, Inc. (NASDAQ:NEPH) Just Reported And Analysts Have Been Lifting Their Price Targets", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros (NEPH) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/c7bf4a95-319f-314d-8718-c46c3d2138dc/nephros-%28neph%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-08T20:10:16+00:00", "published_display": "08 May 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/3dce6705-1f0a-305d-85e1-2a860507bb13/nephros%2C-inc.-q1-2026.html", "source_name": "Moby", "published_at": "2026-05-08T12:30:00+00:00", "published_display": "08 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Announces Financial Results for Quarter Ended March 31, 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/nephros-announces-financial-results-quarter-200500912.html", "source_name": "GlobeNewswire", "published_at": "2026-05-07T20:05:00+00:00", "published_display": "07 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Schedules First Quarter 2026 Financial Results Conference Call", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/nephros-schedules-first-quarter-2026-200000624.html", "source_name": "GlobeNewswire", "published_at": "2026-04-30T20:00:00+00:00", "published_display": "30 Apr 2026 20:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros, Inc. Expands Regional Focus in Greater New York City with Appointment of Dana Cunningham as Sales Leader", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPVTM1aGtjTHdnQVd5ZzJLZGlhQlRvVTZzelBEMDVLdEp3V09HTDBzc3VYNmFoYXJ2MjhYRnp1TWRlaVMtRkdYX2o3ekZfWHF4a292R2xmUDN5NmlmLUVOZFRDeHQ3b280a3FrRW5LREJyck8wTExDaXpKMll4Q1RmSkg0eDFDakRKWHhqX3ZqQTlNTTQ0VHNDYlJxbjRqZ3pQdTlFMWNXN09uTS10SHNRY2IyYmxneTNtc2pVY3BRRUR0QUJSUmx0eXZabFcxajJPY0hTTS1pYVJCV1NqYXF0T3BB?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros, Inc.'s (NASDAQ:NEPH) Popularity With Investors Under Threat As Stock Sinks 28%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros (NEPH) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBqVlR2WTVlb29pVWRnTm0ycG9SazFnblY4VlNhU195NnhMZ1BkX3VSbXNtdjMxd1NOLTE4dFZyc3ZFRVVVWG5uZlp6QUNXb1phbm9n?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T00:05:10+00:00", "published_display": "25 Apr 2025 00:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What is the current Price Target and Forecast for Nephros (NEPH)", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTFByd29NcDdZRkhTR0hxa3lFYkRKNmhyRXNoelZxc19aS29RN2xjN1Q0UWwyUUVJcUxnMFIwQ3Z1WWpTSXRWelh4YURmOGdNUDJ4MTdjTFlYNmFyU21yM3FSRTg4QVVXOFVLWHlZeUVrc09nSmtYNHJnNQ?oc=5", "source_name": "Zacks Investment Research", "published_at": "2023-05-03T07:07:22+00:00", "published_display": "03 May 2023 07:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nephros Stock Price Forecast. Should You Buy NEPH?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSEFVX3lxTFAySThsWGMxdWdrRkRXMjdDWkhjVVRuSTkxdmRnNHZjTVlxQ25oNFFFcjZqTlFrSnloRlk3OUx2dlFBRmg3Q29VVg?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-01T20:28:58+00:00", "published_display": "01 Dec 2020 20:28", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should I buy Nephros (NEPH)", "summary": "", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE55Q0xwMUlaM09PRE93N0xRWFRSVkt1bEZCb1l0WUxmQ3hOMUdEaVBqY3h3S3RTVzB0ME1fN2VON01JTUxYejZ0enIxTTRPU2V6VVJVZERBbDNpR0tORnFEZ2tzaUJLRUxrN3R4Uw?oc=5", "source_name": "Zacks Investment Research", "published_at": "2016-08-05T20:33:11+00:00", "published_display": "05 Aug 2016 20:33", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 83, "total_relevant": 44, "sentiment_summary": {"positive": 20, "negative": 2, "neutral": 22, "score": 59, "total": 44, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 14.65, "count": 26}, {"event": "earnings", "label": "Earnings", "weight": 7.7, "count": 14}, {"event": "guidance", "label": "Guidance", "weight": 1.45, "count": 2}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 20, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 3.63, "latest_week": "2026-07-10", "one_week_move": 6.8, "four_week_move": 8.7, "twelve_week_move": 23.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.405451, "market_dynamics_buy_signal": false, "relative_strength": -23.419754, "fair_value_gap": 30.8, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 37.4183, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+6.8% over one week, +8.7% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 69, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingKey", "count": 7}, {"label": "Stock Titan", "count": 5}, {"label": "TradingView", "count": 4}, {"label": "Moomoo", "count": 3}, {"label": "www.marketscreener.com", "count": 2}, {"label": "The Manila Times", "count": 2}, {"label": "Finviz", "count": 2}, {"label": "Donan\u0131mHaber", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 44}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 26}, {"label": "Earnings", "count": 14}, {"label": "Guidance", "count": 2}, {"label": "Capital return", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "59/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "44", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+6.8% over one week, +8.7% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Price to sales forward of Nephros, Inc. \u2013 NASDAQ:NEPH"}], "updated_at": "2026-07-16T09:26:35.023988+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}